AU2001264002A1 - Acetazolamide-based ophthalmic solution - Google Patents

Acetazolamide-based ophthalmic solution

Info

Publication number
AU2001264002A1
AU2001264002A1 AU2001264002A AU6400201A AU2001264002A1 AU 2001264002 A1 AU2001264002 A1 AU 2001264002A1 AU 2001264002 A AU2001264002 A AU 2001264002A AU 6400201 A AU6400201 A AU 6400201A AU 2001264002 A1 AU2001264002 A1 AU 2001264002A1
Authority
AU
Australia
Prior art keywords
acetazolamide
ophthalmic solution
based ophthalmic
solution
ophthalmic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001264002A
Other languages
English (en)
Inventor
Christine Doucine
Virginie Masson
Bernard Pages
Odile Sechoy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Chauvin SAS
Original Assignee
Laboratoires Chauvin SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Chauvin SAS filed Critical Laboratoires Chauvin SAS
Publication of AU2001264002A1 publication Critical patent/AU2001264002A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nanotechnology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2001264002A 2000-05-23 2001-05-22 Acetazolamide-based ophthalmic solution Abandoned AU2001264002A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0006578A FR2809311A1 (fr) 2000-05-23 2000-05-23 Solution ophtalmique a base d'acetazolamide destinee au traitement du glaucome
FR0006578 2000-05-23
PCT/FR2001/001582 WO2001089578A1 (fr) 2000-05-23 2001-05-22 Solution ophthalmique a base d'acetazolamide

Publications (1)

Publication Number Publication Date
AU2001264002A1 true AU2001264002A1 (en) 2001-12-03

Family

ID=8850522

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001264002A Abandoned AU2001264002A1 (en) 2000-05-23 2001-05-22 Acetazolamide-based ophthalmic solution

Country Status (3)

Country Link
AU (1) AU2001264002A1 (fr)
FR (1) FR2809311A1 (fr)
WO (1) WO2001089578A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101351199B (zh) 2005-12-27 2013-01-02 狮王株式会社 软性接触镜用组合物及吸附抑制方法
WO2018138621A1 (fr) 2017-01-27 2018-08-02 Innovative Nano & Micro Technologies Pvt Ltd (Inm Technologies) Solution ophtalmique à base d'acétazolamide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents

Also Published As

Publication number Publication date
FR2809311A1 (fr) 2001-11-30
WO2001089578A1 (fr) 2001-11-29

Similar Documents

Publication Publication Date Title
AU2002222659A1 (en) Film-reinforced glasses
AU2001262847A1 (en) Language-understanding
AU2001254546A1 (en) Aminopiperidines
AU2000267458A1 (en) Hypercomputer
AU2001288040A1 (en) Homeostasis-maintaining agents
AU2002214284A1 (en) Anti-helicobacterial agents
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2001258349A1 (en) Bisacylguanidine
AU2001279754A1 (en) Indoloquinazolinones
AU2002223503A1 (en) Decondenser unit
AU5495101A (en) Ophthalmic injector
AU2001258924A1 (en) Microsatellite-aflp
AU4309700A (en) Spectacles
AU2001290325A1 (en) Eye drops
AU3328600A (en) Ocular tension-lowering agents
AU2002212234A1 (en) Stable ophthalmic preparation
AU2001246864A1 (en) Hypotensors
AU2001266204A1 (en) Eyewear
AU2001260192A1 (en) Glycinamides
AU2001226668A1 (en) Crankshaft-starter-generator
AU2001262711A1 (en) Cytoprotectors
AU2001264002A1 (en) Acetazolamide-based ophthalmic solution
AU2002219846A1 (en) Novel use
AU2001275014A1 (en) Imidazoloisoquinolines